Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma.
colorectal adenocarcinoma
intratumour heterogeneity
mutational burden
pulmonary enteric adenocarcinoma
whole-exome sequencing
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
04 Aug 2021
04 Aug 2021
Historique:
received:
02
06
2021
revised:
22
07
2021
accepted:
31
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Pulmonary enteric adenocarcinoma (PEAC) is a rare variant of lung adenocarcinoma first described in the early 1990s in a lung tumour with overlapping lung and small intestine features. It is a rare tumour with fewer than 300 cases described in the published literature and was only formally classified in 2011. Given these characteristics the diagnosis is challenging, but even more so in a patient with prior gastrointestinal malignancy. A 68-year-old Caucasian female presented with a cough and was found to have a right upper lobe mass. Her history was significant for a pT3N1 colon adenocarcinoma. The resected lung tumour showed invasive lung adenocarcinoma but also features of colorectal origin. Immuno-stains were strongly and diffusely positive for lung and enteric markers. Multi-region, whole-exome sequencing of the mass and archival tissue from the prior colorectal cancer showed distinct genomic signatures with higher mutational burden in the PEAC and very minimal overlap in mutations between the two tumours. This case highlights the challenge of diagnosing rare lung tumours, but more specifically PEAC in a patient with prior gastro-intestinal cancer. Our use of multi-region, next-generation sequencing revealed distinct genomic signatures between the two tumours further supporting our diagnosis, and evidence of PEAC intra-tumour heterogeneity.
Identifiants
pubmed: 34442412
pii: jpm11080768
doi: 10.3390/jpm11080768
pmc: PMC8398793
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Cancer. 1991 Oct 15;68(8):1754-7
pubmed: 1913519
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Expert Rev Mol Med. 2020 Apr 28;22:e1
pubmed: 32340641
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Medicine (Baltimore). 2017 Sep;96(39):e8153
pubmed: 28953659
J Cancer Res Clin Oncol. 2019 Jan;145(1):269-279
pubmed: 30415301
Int J Clin Exp Pathol. 2014 Feb 15;7(3):1266-74
pubmed: 24696747
Ann Oncol. 2015 Jan;26(1):64-70
pubmed: 25319062
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Clin Colorectal Cancer. 2018 Jun;17(2):97-103
pubmed: 29519711
N Engl J Med. 2020 Aug 13;383(7):640-649
pubmed: 32786189
J Transl Med. 2018 Mar 27;16(1):81
pubmed: 29587865
Clin Chest Med. 2020 Mar;41(1):1-24
pubmed: 32008623
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Int J Clin Exp Pathol. 2017 Sep 01;10(9):9583-9590
pubmed: 31966835
Mod Pathol. 2019 Jun;32(6):855-865
pubmed: 30723296
Arch Pathol Lab Med. 2013 Jun;137(6):828-60
pubmed: 23551194
Bioinformatics. 2010 Aug 15;26(16):2069-70
pubmed: 20562413
Exp Mol Pathol. 2017 Apr;102(2):276-279
pubmed: 28237660
J Thorac Oncol. 2011 Feb;6(2):244-85
pubmed: 21252716
J Thorac Oncol. 2021 Jul 8;:
pubmed: 34246791
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
N Engl J Med. 2020 Oct 29;383(18):1711-1723
pubmed: 32955177
Cancers (Basel). 2020 Jul 06;12(7):
pubmed: 32640573
Appl Immunohistochem Mol Morphol. 2018 Jul;26(6):383-387
pubmed: 27753661
Genome Biol. 2016 Feb 22;17:31
pubmed: 26899170